[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biote Corp (BTMD)

Biote Corp (BTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,365
  • Shares Outstanding, K 37,581
  • Annual Sales, $ 192,220 K
  • Annual Income, $ 27,050 K
  • EBIT $ 18 M
  • EBITDA $ 40 M
  • 60-Month Beta 1.64
  • Price/Sales 0.30
  • Price/Cash Flow 2.65
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.05
  • Number of Estimates 2
  • High Estimate $-0.01
  • Low Estimate $-0.09
  • Prior Year $0.22
  • Growth Rate Est. (year over year) -122.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4000 +6.43%
on 08/12/26
2.6000 -42.69%
on 07/21/26
-0.8300 (-35.78%)
since 07/13/26
3-Month
1.4000 +6.43%
on 08/12/26
2.6000 -42.69%
on 07/21/26
-0.5400 (-26.60%)
since 05/13/26
52-Week
1.2700 +17.32%
on 03/30/26
3.6200 -58.84%
on 09/03/25
-1.5800 (-51.47%)
since 08/13/25

Most Recent Stories

More News
Biote Reports Second Quarter 2026 Financial Results

Continued progress in advancing strategic initiatives Updates full-year outlook Second Quarter 2026 Financial Highlights ...

BTMD : 1.4900 (+4.93%)
Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners’ patients, today...

BTMD : 1.4900 (+4.93%)
Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

Biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) today announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr. Bajaj is...

BTMD : 1.4900 (+4.93%)
Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

Bret Christensen Stepping Down as CEO for Family and Personal Reasons, Remains a Director Company Reaffirms Full Year 2026 Guidance

BTMD : 1.4900 (+4.93%)
Biote Reports First Quarter 2026 Financial Results

Sales team expansion on track and nearing targeted level Return to procedure growth expected in second half of 2026 First Quarter...

BTMD : 1.4900 (+4.93%)
Biote Schedules First Quarter 2026 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners’ patients, today...

BTMD : 1.4900 (+4.93%)
Biote Reports Fourth Quarter and Full Year 2025 Financial Results

Executing efficiently on strategic priorities Continued salesforce expansion to capture large growth opportunity Anticipate a return...

BTMD : 1.4900 (+4.93%)
Should Risk-Takers Roll the Dice on These 3 Penny Stocks at 52-Week Lows?

The Iran war has reduced the number of new 52-week highs on the NYSE and Nasdaq, and new 52-week lows now dominate across both exchanges. Among the 157 stocks hitting new 52-week lows, three penny stocks...

KLC : 4.83 (+4.09%)
$SPX : 7,798.99 (+0.65%)
BTMD : 1.4900 (+4.93%)
AIV : 2.61 (unch)
Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients’ lives by providing hormone replacement therapy and healthy aging solutions, today...

BTMD : 1.4900 (+4.93%)
Biote Reports Third Quarter 2025 Financial Results

Continued progress against strategic priorities Repurchased approximately one million shares of Class A common stock Reiterates 2025...

BTMD : 1.4900 (+4.93%)

Business Summary

BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 1.6333
2nd Resistance Point 1.5967
1st Resistance Point 1.5433
Last Price 1.4900
1st Support Level 1.4533
2nd Support Level 1.4167
3rd Support Level 1.3633

See More

52-Week High 3.6200
Fibonacci 61.8% 2.7223
Fibonacci 50% 2.4450
Fibonacci 38.2% 2.1677
Last Price 1.4900
52-Week Low 1.2700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.